These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29849291)

  • 21. Euglycemic Diabetic Ketoacidosis, a Misleading Presentation of Diabetic Ketoacidosis.
    Thawabi M; Studyvin S
    N Am J Med Sci; 2015 Jun; 7(6):291-4. PubMed ID: 26199928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketoacidosis in a Patient with Type 2 Diabetes Requiring Alpelisib: Learnings and Observations Regarding Alpelisib Initiation and Rechallenge.
    Leung M; Rodrigues P; Roitman D
    Onco Targets Ther; 2022; 15():1309-1315. PubMed ID: 36330532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic ketoacidosis and acute mountain sickness: case report and review of treatment options in type 1 diabetes mellitus.
    Miller SC
    Wilderness Environ Med; 2015 Jun; 26(2):185-8. PubMed ID: 25899916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature.
    Bonora BM; Avogaro A; Fadini GP
    Diabetes Obes Metab; 2018 Jan; 20(1):25-33. PubMed ID: 28517913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based incidence of diabetic ketoacidosis in type 2 diabetes: medical claims data analysis in Japan.
    Takeuchi M; Kawamura T; Sato I; Kawakami K
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):123-126. PubMed ID: 28752620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report.
    Wang KM; Isom RT
    Kidney Med; 2020; 2(2):218-221. PubMed ID: 32734242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes.
    Peters AL; Henry RR; Thakkar P; Tong C; Alba M
    Diabetes Care; 2016 Apr; 39(4):532-8. PubMed ID: 26989182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic encephalopathy secondary to diabetic ketoacidosis: a case report.
    Tomkins M; McCormack R; O'Connell K; Agha A; Merwick Á
    BMC Endocr Disord; 2019 Jul; 19(1):71. PubMed ID: 31266485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpelisib-Induced Diabetic Ketoacidosis in a Non-diabetic Patient.
    Fugere T; Roy AM; Makhoul I
    Cureus; 2021 Nov; 13(11):e19295. PubMed ID: 34900474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin.
    Bader N; Mirza L
    Pak J Med Sci; 2016; 32(3):786-8. PubMed ID: 27375734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management.
    Kum-Nji JS; Gosmanov AR; Steinberg H; Dagogo-Jack S
    J Diabetes Complications; 2017 Mar; 31(3):611-614. PubMed ID: 27913012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Euglycemic clamp study in clozapine-induced diabetic ketoacidosis.
    Avram AM; Patel V; Taylor HC; Kirwan JP; Kalhan S
    Ann Pharmacother; 2001 Nov; 35(11):1381-7. PubMed ID: 11724088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis.
    Hampp C; Swain RS; Horgan C; Dee E; Qiang Y; Dutcher SK; Petrone A; Chen Tilney R; Maro JC; Panozzo CA
    Diabetes Care; 2020 Jan; 43(1):90-97. PubMed ID: 31601640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel visits in emergency department patients with diabetes mellitus as a warning sign for hyperglycemic emergencies.
    Yan JW; Gushulak KM; Columbus MP; Hamelin AL; Wells GA; Stiell IG
    CJEM; 2018 Mar; 20(2):230-237. PubMed ID: 28738911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Euglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report.
    Mendelsohn RA; Taveras AN; Mazer BA; Clayton LM
    Clin Pract Cases Emerg Med; 2020 Aug; 4(3):389-392. PubMed ID: 32926693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroid-Induced Diabetic Ketoacidosis: A Case Report and Review of the Literature.
    Cavataio MM; Packer CD
    Cureus; 2022 Apr; 14(4):e24372. PubMed ID: 35611043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin.
    Sexe J; Mayes C; Tofts P
    Case Rep Crit Care; 2020; 2020():7437892. PubMed ID: 32695525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diabetic ketoacidosis with mild hyperglycemia associated with the use of canagliflozin. Report of one case with type 1 diabetes].
    Novik A V; García B C; Oliva I D
    Rev Med Chil; 2017 Mar; 145(3):393-396. PubMed ID: 28548198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catamenial diabetic ketoacidosis and catamenial hyperglycemia: case report and review of the literature.
    Ovalle F; Vaughan TB; Sohn JE; Gower B
    Am J Med Sci; 2008 Apr; 335(4):298-303. PubMed ID: 18414069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral gangrene of fingers in a patient on empagliflozin: First case report.
    Ramachandra Pai RP; Kangath RV
    World J Diabetes; 2019 Feb; 10(2):133-136. PubMed ID: 30788049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.